Evidence map›Paper›PMID 42816552›Full record

ArticleNature communications2026

Sphingolipids associate with the chlamydial nucleoid and mark developmental transitions in Chlamydia trachomatis.

Marcel Rühling, Fabienne Wagner, Till Epprecht, Paul F Köhling, Fabian Schumacher, Stefan Sachs, Louise Kersting, Julian Fink, Lina Girndt, Burkhard Kleuser and 4 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Marcel Rühling *Chair of Microbiology, Julius-Maximilians-University Würzburg, Am Hubland, 97074, Würzburg, Germany. marcel.ruehling@uni-wuerzburg.de.ORCID 0009-0006-4757-5014
Fabienne Wagner *Chair of Microbiology, Julius-Maximilians-University Würzburg, Am Hubland, 97074, Würzburg, Germany.ORCID 0009-0006-7828-026X
Till EpprechtInstitute of Medical Microbiology, University of Zürich, Gloriastrasse 28/30, 8006, Zürich, Switzerland.ORCID 0000-0001-5931-4897
Paul F KöhlingChair of Microbiology, Julius-Maximilians-University Würzburg, Am Hubland, 97074, Würzburg, Germany.ORCID 0009-0004-7029-1111
Fabian SchumacherInstitute of Pharmacy, Freie Universität Berlin, Königin-Luise-Straße 2+4, 14195, Berlin, Germany.ORCID 0000-0001-8703-3275
Stefan SachsChair of Biotechnology & Biophysics, Biocenter, Julius-Maximilians-University Würzburg, Am Hubland, 97074, Würzburg, Germany.
Louise KerstingInstitute of Organic Chemistry, Julius-Maximilians-University Würzburg, Am Hubland, 97074, Würzburg, Germany.
Julian FinkInstitute of Organic Chemistry, Julius-Maximilians-University Würzburg, Am Hubland, 97074, Würzburg, Germany.
Lina GirndtInstitute of Organic Chemistry, Julius-Maximilians-University Würzburg, Am Hubland, 97074, Würzburg, Germany.
Burkhard KleuserInstitute of Pharmacy, Freie Universität Berlin, Königin-Luise-Straße 2+4, 14195, Berlin, Germany.ORCID 0000-0002-1888-9595
Markus SauerChair of Biotechnology & Biophysics, Biocenter, Julius-Maximilians-University Würzburg, Am Hubland, 97074, Würzburg, Germany.ORCID 0000-0002-1692-3219
Jürgen SeibelInstitute of Organic Chemistry, Julius-Maximilians-University Würzburg, Am Hubland, 97074, Würzburg, Germany.ORCID 0000-0002-8036-4853
Gregor L WeissInstitute of Medical Microbiology, University of Zürich, Gloriastrasse 28/30, 8006, Zürich, Switzerland.ORCID 0000-0002-2132-670X
Thomas RudelChair of Microbiology, Julius-Maximilians-University Würzburg, Am Hubland, 97074, Würzburg, Germany. thomas.rudel@uni-wuerzburg.de.ORCID 0000-0003-4740-6991

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) 116162193Deutsche Forschungsgemeinschaft (German Research Foundation) FOR3004 SYNABS, SA829/19-1Deutsche Forschungsgemeinschaft (German Research Foundation) INST93/1159-1 FUGGDeutsche Forschungsgemeinschaft (German Research Foundation) RTG 2581Deutsche Forschungsgemeinschaft (German Research Foundation) SFB 1583EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 835102EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) ERC-2018-ADG/NCI-CADSchweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) TMSGI3_226208
6 · The paper itself

Abstract

Chlamydia trachomatis is an obligate intracellular bacterial pathogen and a leading cause of sexually transmitted infections worldwide. During its biphasic developmental cycle, infectious, non-replicative elementary bodies alternate with replicative reticulate bodies within a membrane-bound intracellular niche known as the inclusion. C. trachomatis relies heavily on host-derived metabolites, including sphingolipids, which are essential for inclusion integrity, bacterial growth and production of infectious progeny. Here, using expansion microscopy, we uncover an unexpected localization of sphingolipid derivatives within the highly condensed DNA nucleoids of elementary bodies. These sphingolipids are released from nucleoids prior to DNA decondensation during the elementary-to-reticulate body transition, the earliest phenotypic event in the complex developmental cycle of these bacteria. Thereafter, nucleoids undergo a characteristic DNA decondensation process that we visualized by expansion microscopy. By combining super-resolution imaging with a FRET-based metabolic tracking approach and lipidomics, we identified sphingomyelin derived from the sphingolipid analogues as the sphingolipid species predominantly associated with the condensing nucleoids of elementary bodies. Notably, reticulate bodies arrested in their developmental stage fail to accumulate sphingomyelin, suggesting a potential role for this lipid in stage-specific DNA condensation.

Indexed as

Chlamydia trachomatisSphingolipidsDNA, BacterialHeLa CellsHumansSphingomyelinsDNA, BacterialSphingolipidsSphingomyelins

Identifiers

PMID42816552
PMCPMC13627705

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.